Fujun Wang

机构：Qiqihar Medical University · ORCID：0000-0002-2851-6709

发表论文 30 篇 · 总被引 390 次 · h-index 9

代表论文

• Membrane Fusion‐Mediated Loading of Therapeutic siRNA into Exosome for Tissue‐Specific Application (2024 · Advanced Materials · 被引 88)
• LncRNA MALAT1 induces the dysfunction of β cells via reducing the histone acetylation of the PDX-1 promoter in type 1 diabetes (2020 · Experimental and Molecular Pathology · 被引 74)
• CCL5 secreted by tumor associated macrophages may be a new target in treatment of gastric cancer (2015 · Biomedicine & Pharmacotherapy · 被引 65)
• Effect of SGLT2 inhibitors versus DPP4 inhibitors or GLP-1 agonists on diabetic foot-related extremity amputation in patients with T2DM: A meta-analysis (2021 · Primary care diabetes · 被引 24)
• Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours (2023 · BMC Cancer · 被引 19)
• Enhancing tumor-specific intracellular delivering efficiency of cell-penetrating peptide by fusion with a peptide targeting to EGFR (2015 · Amino Acids · 被引 18)